Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Lilly's triple agonist retatrutide posted 28.7% weight loss in TRIUMPH-4 Phase 3, the highest figure from any GLP-1-class drug to date
A study of 168 pregnancies with first-trimester exposure to GLP-1s did not show increased chance of miscarriage, preterm delivery, stillbirth, or SGA infants (small for gestational age-infants whose birth weight is below the 10 th percentile for their gestation age)
Central Florida Orlando, Kissimmee, Winter Park, Clermont, Tampa, St
Retatrutide 12 mg produced 24.2% at 48 weeks [1], a shorter trial with a steeper loss curve
US$ 23.86
US$ 22.47
US$ 20.20
US$ 21.70
US$ 28.33
US$ 23.35
